PlumX Metrics
Embed PlumX Metrics

SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021)

Clinical and Translational Oncology, ISSN: 1699-3055, Vol: 24, Issue: 4, Page: 703-711
2022
  • 5
    Citations
  • 0
    Usage
  • 41
    Captures
  • 0
    Mentions
  • 10
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    5
  • Captures
    41
  • Social Media
    10
    • Shares, Likes & Comments
      10
      • Facebook
        10

Article Description

Central nervous system (CNS) dissemination is a severe complication in cancer and a leading cause of cancer-related mortality. Brain metastases (BMs) are the most common types of malignant intracranial tumors and are reported in approximately 25% of patients with metastatic cancers. The recent increase in incidence of BMs is due to several factors including better diagnostic assessments and the development of improved systemic therapies that have lower activity on the CNS. However, newer systemic therapies are being developed that can cross the blood–brain barrier giving us additional tools to treat BMs. The guidelines presented here focus on the efficacy of new targeted systemic therapies and immunotherapies on CNS BMs from breast, melanoma, and lung cancers.

Bibliographic Details

Martínez-García, María; Servitja Tormo, Sonia; Vilariño Quintela, Noelia; Arance Fernández, Ana; Berrocal Jaime, Alfonso; Cantos Sánchez de Ibargüen, Blanca; Del Barco Berrón, Sonia; García Campelo, Rosario; Gironés Sarrió, Regina; Manuel Sepúlveda-Sánchez, Juan

Springer Science and Business Media LLC

Medicine; Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know